• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明胶纤维蛋白凝血酶在治疗严重肝出血中的有效性:一项实验研究。

Effectiveness of a thrombin-gelatin flowable for treating severe liver bleeding: an experimental study.

机构信息

General and Digestive Unit, Central Hospital of Defense Gómez Ulla, Glorieta del Ejército, 1, Madrid, (28047), Spain.

University of Alcalá de Henares, Madrid, Spain.

出版信息

BMC Gastroenterol. 2024 Feb 14;24(1):71. doi: 10.1186/s12876-023-03114-6.

DOI:10.1186/s12876-023-03114-6
PMID:38355409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10865537/
Abstract

BACKGROUND

Current scientific evidence has pointed out the relevance of hemostatic products for improving clinical outcomes in liver trauma, including increased survival rates and reductions in bleeding-related complications. The purpose of this study was to compare the use of the gelatin-thrombin flowable (Flowable) versus the standard technique of Packing in a new experimental liver injury model.

METHODS

Twenty-four swine were prospectively randomized to receive either Flowable or standard packing technique. We used a novel severe liver injury model, in which the middle and left suprahepatic veins were selectively injured, causing an exsanguinating hemorrhage. The main outcome measure was the percentage of lost blood volume.

RESULTS

The median total percentage of total blood volume per animal lost, from injury to minute 120, was significantly lower in the Flowable group (15.2%; interquartile range: 10.7-46.7%) than in the Packing group (64.9%; Interquartile range: 53.4-73.0%) (Hodges-Lehmann median difference: 41.1%; 95% CI: 18.9-58.0%, p = 0.0034). The 24-hour survival rate was significantly higher in the Flowable group (87.0%) than in the Packing group (0.0%) (Hazard ratio (HR) 0.08; 95% confidence interval 0.102 to 0.27; p < 0.0001). Mean-arterial pressure was significantly lower at minute 60 and 120 in the Flowable group than in the packing group (p = 0.0258 and p = 0.0272, respectively). At minute 120, hematocrit was higher in the Flowable than in the packing group (Hodges-Lehmann median difference: 5.5%; 95%CI: 1.0 to11.0, p = 0.0267). Finally, the overall-surgical-procedure was significantly shorter with Flowable than with Packing (Hodges-Lehmann median difference: 39.5 s, 95% CI: 25.0 to 54.0 s, p = 0.0004).

CONCLUSIONS

The use of the Flowable was more effective in achieving hemostasis, reducing blood loss, and improving survival rates than standard packing in a severe porcine-liver bleeding model.

摘要

背景

目前的科学证据指出,止血产品对于改善肝外伤的临床结果具有相关性,包括提高存活率和减少与出血相关的并发症。本研究的目的是比较在新的实验性肝损伤模型中使用明胶-凝血酶可流动(Flowable)与标准填塞技术的效果。

方法

24 头猪前瞻性随机分为接受 Flowable 或标准填塞技术。我们使用了一种新的严重肝损伤模型,其中选择性损伤肝上下腔静脉,导致出血性出血。主要观察指标是动物失去的总血容量百分比。

结果

从损伤到第 120 分钟,每只动物总血容量损失的中位数百分比在 Flowable 组(15.2%;四分位距:10.7-46.7%)明显低于填塞组(64.9%;四分位距:53.4-73.0%)(Hodges-Lehmann 中位数差异:41.1%;95%CI:18.9-58.0%,p=0.0034)。Flowable 组 24 小时生存率明显高于填塞组(87.0%对 0.0%)(风险比(HR)0.08;95%置信区间 0.102 至 0.27;p<0.0001)。Flowable 组在第 60 分钟和 120 分钟时平均动脉压明显低于填塞组(p=0.0258 和 p=0.0272)。在第 120 分钟时,Flowable 组的血细胞比容高于填塞组(Hodges-Lehmann 中位数差异:5.5%;95%CI:1.0 至 11.0,p=0.0267)。最后,Flowable 的总体手术时间明显短于填塞(Hodges-Lehmann 中位数差异:39.5 秒,95%CI:25.0 至 54.0 秒,p=0.0004)。

结论

在严重猪肝出血模型中,与标准填塞相比,Flowable 在实现止血、减少失血和提高存活率方面更有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/0095d330f615/12876_2023_3114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/a8a8c0164204/12876_2023_3114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/3c4443b38be7/12876_2023_3114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/8048f92aa97a/12876_2023_3114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/701898e16820/12876_2023_3114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/ca7789e82061/12876_2023_3114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/9c23f6ecb7aa/12876_2023_3114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/0095d330f615/12876_2023_3114_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/a8a8c0164204/12876_2023_3114_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/3c4443b38be7/12876_2023_3114_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/8048f92aa97a/12876_2023_3114_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/701898e16820/12876_2023_3114_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/ca7789e82061/12876_2023_3114_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/9c23f6ecb7aa/12876_2023_3114_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/10865537/0095d330f615/12876_2023_3114_Fig7_HTML.jpg

相似文献

1
Effectiveness of a thrombin-gelatin flowable for treating severe liver bleeding: an experimental study.明胶纤维蛋白凝血酶在治疗严重肝出血中的有效性:一项实验研究。
BMC Gastroenterol. 2024 Feb 14;24(1):71. doi: 10.1186/s12876-023-03114-6.
2
Comparison of a gelatin thrombin versus a modified absorbable polymer as a unique treatment for severe hepatic hemorrhage in swine.明胶纤维蛋白原与改良可吸收聚合物治疗猪严重肝出血的对比研究。
Sci Rep. 2023 Nov 27;13(1):20854. doi: 10.1038/s41598-023-41983-9.
3
Efficacy, safety, and physicochemical properties of a flowable hemostatic agent made from absorbable gelatin sponge via vacuum pressure steam sterilization.经真空压力蒸汽灭菌的可吸收明胶海绵制成的流动性止血剂的功效、安全性和理化性质。
J Biomater Appl. 2021 Feb;35(7):776-789. doi: 10.1177/0885328220950899. Epub 2020 Aug 24.
4
Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.两种明胶与凝血酶组合止血剂在猪肝擦伤模型中的比较。
J Invest Surg. 2013 Jun;26(3):141-8. doi: 10.3109/08941939.2012.724519. Epub 2013 Mar 20.
5
A Comparative Efficacy Evaluation of Recombinant Topical Thrombin (RECOTHROM) With A Gelatin Sponge Carrier Versus Topical Oxidized Regenerated Cellulose (TABOTAMP/SURGICEL) In A Porcine Liver Bleeding Model.一种新型重组局部外用凝血酶(RECOTHROM)凝胶海绵载体与氧化再生纤维素(TABOTAMP/SURGICEL)局部外用在猪肝脏出血模型中的疗效比较评估。
J Invest Surg. 2021 Aug;34(8):862-868. doi: 10.1080/08941939.2019.1705444. Epub 2020 Jan 20.
6
Similar patient outcomes yet different hospital costs between flowable hemostatic agents.可流动止血剂之间患者预后相似但医院成本不同。
J Med Econ. 2015;18(9):735-45. doi: 10.3111/13696998.2015.1044994. Epub 2015 Jun 8.
7
Cost-consequence analysis of a hemostatic matrix alone or in combination for spine surgery patients.单独或联合使用止血基质对脊柱手术患者的成本-后果分析。
J Med Econ. 2018 Oct;21(10):1041-1046. doi: 10.1080/13696998.2018.1513261. Epub 2018 Aug 30.
8
Comparison the efficacy of hemorrhage control of Surgiflo Haemostatic Matrix and absorbable gelatin sponge in posterior lumbar surgery: A randomized controlled study.Surgiflo止血基质与可吸收明胶海绵在腰椎后路手术中止血效果的比较:一项随机对照研究。
Medicine (Baltimore). 2018 Dec;97(49):e13511. doi: 10.1097/MD.0000000000013511.
9
An Efficacy Comparison of Two Hemostatic Agents in a Porcine Liver Bleeding Model: Gelatin/Thrombin Flowable Matrix versus Collagen/Thrombin Powder.两种止血剂在猪肝脏出血模型中的疗效比较:明胶/凝血酶可流动基质与胶原/凝血酶粉。
J Invest Surg. 2020 Oct;33(9):828-838. doi: 10.1080/08941939.2019.1571130. Epub 2019 Mar 24.
10
An In Vivo Comparison of Hemostatic Gelatin Matrix Products in a Porcine Spleen Biopsy-punch Model.猪脾脏活检穿刺模型中止血明胶基质产品的体内比较
Surg Technol Int. 2015 Nov;27:53-7.

引用本文的文献

1
A comparative analysis of collagen based dressings and polysaccharide microspheres for hemostasis management in hepatic stab wounds.基于胶原蛋白的敷料与多糖微球用于肝刺伤止血管理的比较分析
Sci Rep. 2025 Jan 30;15(1):3802. doi: 10.1038/s41598-024-84721-5.

本文引用的文献

1
Comparison of a gelatin thrombin versus a modified absorbable polymer as a unique treatment for severe hepatic hemorrhage in swine.明胶纤维蛋白原与改良可吸收聚合物治疗猪严重肝出血的对比研究。
Sci Rep. 2023 Nov 27;13(1):20854. doi: 10.1038/s41598-023-41983-9.
2
Construction and validation of a novel and severe hepatic injury model in swine focuses on research and training. Observational study.构建并验证一种新型严重猪肝损伤模型,重点在于研究与培训。观察性研究。
MethodsX. 2023 Sep 3;11:102362. doi: 10.1016/j.mex.2023.102362. eCollection 2023 Dec.
3
Utility of microporous polysaccharide hemospheres in severe hepatic trauma: Experimental study of hemostatic strength and ease of use.
微孔多糖球在严重肝外伤中的应用:止血强度和易用性的实验研究。
Injury. 2023 Feb;54(2):339-344. doi: 10.1016/j.injury.2022.11.045. Epub 2022 Nov 20.
4
Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL, in intracranial tumor resection.局部用明胶-凝血酶止血基质FLOSEAL在颅内肿瘤切除术中的疗效
Surg Neurol Int. 2020 Feb 7;11:16. doi: 10.25259/SNI_272_2019. eCollection 2020.
5
Experimental Evaluation of a New Tissue Factor-Based Topical Hemostat (TT-173) for Treatment of Hepatic Bleeding.一种新型基于组织因子的局部止血剂(TT-173)治疗肝出血的实验评估
J Invest Surg. 2020 Apr;33(4):339-349. doi: 10.1080/08941939.2018.1517840. Epub 2018 Oct 31.
6
Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes.脊柱手术中单独使用弗洛塞尔与联合使用的比较:基于医院数据库的临床和医疗资源结果的回顾性比较评估
Hosp Pract (1995). 2018 Oct;46(4):189-196. doi: 10.1080/21548331.2018.1498279. Epub 2018 Jul 23.
7
Using FloSeal to control digestive bleeding in the distal large bowel.使用弗洛塞尔(FloSeal)控制远端大肠的消化性出血。
J Vis Surg. 2018 May 9;4:93. doi: 10.21037/jovs.2018.04.01. eCollection 2018.
8
Uses of FloSeal in obstetric hemorrhage: Case series and literature review.弗洛塞尔(FloSeal)在产科出血中的应用:病例系列及文献综述
Taiwan J Obstet Gynecol. 2017 Dec;56(6):827-830. doi: 10.1016/j.tjog.2017.10.022.
9
Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.人源明胶-凝血酶基质密封剂Floseal®在手术中的应用:一项系统评价
BMC Surg. 2014 Dec 20;14:111. doi: 10.1186/1471-2482-14-111.
10
Experimental models of hemorrhagic shock: a review.失血性休克的实验模型:综述
Eur Surg Res. 2013;50(2):57-70. doi: 10.1159/000348808. Epub 2013 Apr 23.